Vancouver, BC (November 28, 2013) –The Centre for Drug Research and Development (CDRD) and the Prevention of Organ Failure Centre (PROOF Centre), both inaugural Centres of Excellence for Commercialization and Research (CECRs) headquartered in Vancouver, are pleased to announce they …
PROOF Centre and MRM Proteomics Collaborate with the Jain Foundation to Identify Blood-Based Biomarkers of LGMD2B/Miyoshi Muscular Dystrophy
Vancouver, BC and Seattle, WA (October 16, 2013) – The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics Inc. will use their biomarker expertise in collaboration with the Jain Foundation, Inc. to identify blood-based …
Fall 2013 issue of The Marker
The Fall 2013 issue of The Marker is here to keep you abreast of the latest news from the PROOF Centre.
The PROOF Centre of Excellence Partners With HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test
Vancouver, BC (September 25, 2013) –The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics are collaborating to begin clinical validation of a biomarker blood test that will provide early indication of organ rejection …
Biomarker solutions for heart, lung and kidney diseases
Heart, lung and kidney diseases together are responsible for more than 40 per cent of deaths and $3.46 trillion in healthcare spending worldwide. Biotechnology Focus covers how the PROOF Centre is developing cost-effective blood tests for heart, lung and kidney …